Subsyndromal symptoms hasten relapse in BD

By Mark Cowen, Senior medwireNews Reporter

The presence of subsyndromal affective symptoms is associated with a significantly shorter time to relapse among euthymic patients with bipolar disorder (BD), Spanish research shows.

In a study of 225 BD outpatients who were clinically euthymic (without DSM IV-TR criteria for affective episodes) at baseline, median time to relapse was more than two-thirds shorter for those with subsyndromal symptoms at baseline compared with asymptomatic individuals.

"Our work confirms the important role of subsyndromal symptoms as a risk factor for affective relapse in BD patients," comment Consuelo de Dios (University Hospital La Paz, Madrid) and team.

Of the patients, 163 (72.4%) were asymptomatic at baseline, with Hamilton Depression Rating scale (HDRS) and Young Mania Rating scale (YMRS) scores of less than 8, and 62 (27.6%) had subsyndromal symptoms, with HDRS and/or YMRS scores of 8-14.

Over a median follow-up period of 157.6 weeks, 57.3% of the patients experienced at least one affective episode, including depressive (19.2%), manic (5.4%), hypomanic (22.8%), and mixed episodes (10.3%).

The researchers found that median survival time to relapse was 109 weeks in patients who were asymptomatic at baseline compared with 35 weeks in those with subsyndromal symptoms - a significant difference.

The team also found that the presence of psychosocial stress was an independent risk factor for reduced time to relapse among the participants, at a hazard ratio of 2.2.

There were no significant associations between time to relapse and other socio-demographic or clinical variables, including BD subtype, predominant polarity or illness duration, they note.

Writing in the Journal of Affective Disorders, de Dios et al conclude: "Our results show that in a Spanish non-tertiary BD cohort, subsyndromal BD symptoms and psychosocial stress at baseline predict earlier affective episode relapse."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds facial shape differences linked to schizophrenia and bipolar disorder